Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
Tissue Regeneration 3 min read

ARA-290 (Cibinetide): Non-Erythropoietic Tissue Protection, Innate Repair Receptor (IRR) Activation, and Neuropathy Models

Compiled & reviewed by SwissLab Bioenergetics & Compliance Desk — Cellular Bioenergetics, Neuropeptides & RUO Governance Desk
Editorial Standards
Analytical Summary

A molecular study of the erythropoietin-derived peptide ARA-290 (Cibinetide). Selective activation of the Innate Repair Receptor (EPOR/CD131), suppression of microglial activation, and nerve regeneration. ARA-290 (Cibinetide) is an 11-amino-acid peptide engineered from the non-erythropoietic B-helix of erythropoietin (EPO).

Key Research Takeaways
  • ARA-290 (Cibinetide) is an 11-amino-acid peptide engineered from the non-erythropoietic B-helix of erythropoietin (EPO).
  • Selectively binds the Innate Repair Receptor (IRR), a heterodimer composed of EPOR and the common beta receptor (CD131).
  • Does not bind the classical EPOR homodimer, eliminating risks of erythropoiesis, polycythemia, or thrombosis.
  • Demonstrates potent anti-inflammatory and neuroprotective activity in models of small fiber neuropathy and tissue ischemia.
Analytical & Handling Reference Matrix
CAS Registry Number 1208110-38-6
Molecular Formula C51H84N16O21
Molecular Mass 1257.32 g/mol
Primary Biological Target Innate Repair Receptor (EPOR/CD131 Heterodimer)
Analytical Purity Standard ≥99.0% (RP-HPLC, C18, 214/220 nm)
Identity Verification ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%)
Lyophilized Storage -20°C desiccated, protected from UV light (24–36 months)
Reconstituted Storage 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water)

1. Sequence Design: The B-Helix of Erythropoietin

Recombinant human erythropoietin (EPO) exhibits tissue-protective and neuroregenerative properties, but its therapeutic research use is constrained by its primary hematological effect: stimulating red blood cell production via the EPOR homodimer. ARA-290 (Cibinetide, sequence: H-Gln-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH, MW 1257.32 Da) was synthesized by isolating the 11-amino-acid linear sequence corresponding to the aqueous-exposed surface of EPO's Helix B, retaining tissue repair activity while completely decoupling from erythropoiesis.

2. Selective Innate Repair Receptor (IRR) Signaling

The Innate Repair Receptor (IRR) is a heteromeric receptor complex consisting of one erythropoietin receptor (EPOR) subunit and one common beta chain (CD131 / beta-c) subunit. The IRR is transiently expressed by metabolically stressed endothelial cells, neurons, Schwann cells, and macrophages following injury. ARA-290 binds the IRR with nanomolar affinity, triggering anti-apoptotic and anti-inflammatory signaling cascades without cross-reacting with the classical (EPOR)2 homodimer.

3. Neuroprotection and Microglial Inactivation

In rodent models of small fiber neuropathy (SFN) and diabetic neurodegeneration, ARA-290 administration inhibits spinal microglial p38 MAPK phosphorylation and suppresses pro-inflammatory cytokine secretion (TNF-alpha, IL-1beta). This leads to increased intraepidermal nerve fiber density (IENFD) and axonal sprouting in dermal punch biopsy assays.

4. Laboratory Preparation and Stability

ARA-290 is a hydrophilic peptide readily soluble in sterile Bacteriostatic Water and standard phosphate-buffered saline (PBS, pH 7.2–7.4). Store lyophilized powder at -20°C in an airtight container protected from humidity. Reconstituted solutions should be stored at 2°C to 8°C and used within 28 days.

5. Bench Preparation & Assay Reproducibility for ARA-290 (Cibinetide)

When designing in-vitro experiments targeting Innate Repair Receptor (EPOR/CD131 Heterodimer), normalize dosing across replicates by molar concentration (µM or nM) using the published molecular weight (1257.32 g/mol) and batch counterion composition rather than gross powder weight alone. Log lot numbers, diluent pH, and aliquot dates to ensure batch-to-batch reproducibility across longitudinal experiments.

Peer-Reviewed References & Analytical Standards

  1. Brines M. et al. (2008). Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proceedings of the National Academy of Sciences, 105(31), 10925–10930. [PMID: 18676614 ↗]
  2. Swartjes M. et al. (2011). ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain. Anesthesiology, 115(5), 1084–1092. [PMID: 21952254 ↗]

Referenced Laboratory Research Reagents

Batch-verified SwissLab catalog entries cited in this monograph

All 66 Compounds →
Laboratory Compliance & Handling Protocol

All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.

Related Research Monographs

All monographs (44)

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog